Prudent Corporate Advisory Services Limited has made a regulatory disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI (Share Based Employee Benefits) Regulation 2021.
The Nomination & Remuneration Committee (NRC) of the Board of Directors approved the second tranche grant of stock options at its meeting held on October 09, 2026.
Key Details of the ESOP Grant:
- Number of Options Granted: 1,30,845 (One Lakh Thirty Thousand Eight Hundred Forty-Five) Employees Stock Options
- Face Value: Rs. 5/- each
- Eligible Recipients: Employees of the Company and its Wholly Owned Subsidiary, Gennext Insurance Brokers Private Limited
- Grant Price: Rs. 3,211/- (Rupees Three Thousand Two Hundred Eleven Only) per Option
- Pricing Basis: Closing price of the company's equity shares on National Stock Exchange of India Limited on October 08, 2026 (the trading day immediately preceding the grant approval date)
- Scheme Reference: Prudent - Employee Stock Options Scheme 2025
Significant Terms of the Scheme:
- The Scheme is administered by the NRC Committee of the Company
- Minimum Vesting Period: 1 (One) year
- Maximum Vesting Period: 4 (four) years from the date of Grant
- Shares issued upon exercise of Options are freely transferable with no lock-in period restrictions (subject to applicable laws)
- One Option entitles the holder to convert to One Equity Share of face value Rs. 5/-
The disclosure includes an Annexure-A with the required details as per SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
Additional Information:
- The communication was digitally signed by Kunal Amrishbhai Chauhan, Company Secretary (Membership No: FCS-13492)
- Company CIN: L91120GJ2003PLC042458